| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc. | Director | Share Option (right to buy) | 51.8K | Jun 23, 2025 | Direct | ||
| CATALYST BIOSCIENCES, INC. | Director | Stock Option (Right to Buy) | 14K | Jun 9, 2021 | Direct | ||
| DICE Therapeutics, Inc. | Director | Common Stock | 0 | $46.50 | Aug 9, 2023 | Direct | |
| DICE Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Aug 9, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| GPCR | Structure Therapeutics Inc. | Jun 23, 2025 | 1 | $0 | 4 | Jun 25, 2025 | Director |
| GPCR | Structure Therapeutics Inc. | Jun 25, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
| DICE | DICE Therapeutics, Inc. | Aug 9, 2023 | 5 | $0 | 4 | Aug 9, 2023 | Director |
| GPCR | Structure Therapeutics Inc. | Feb 2, 2023 | 0 | $0 | 3 | Feb 2, 2023 | Director |
| DICE | DICE Therapeutics, Inc. | Jun 7, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Director |
| DICE | DICE Therapeutics, Inc. | Sep 14, 2021 | 4 | $0 | 4 | Sep 16, 2021 | Director |
| DICE | DICE Therapeutics, Inc. | Sep 14, 2021 | 0 | $0 | 3 | Sep 14, 2021 | Director |
| CBIO | CATALYST BIOSCIENCES, INC. | Jun 9, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |